Corrigendum to “Results of a randomized, double-blind, placebo-controlled study of mirabegron in a Taiwanese population with overactive bladder and comparison with other clinical trials” [Urol Sci (2015) 41–48] - Hann-Chorng Kuo; Ho-Hsiung Lin; Hong-Jeng Yu; Chen-Li Cheng; Man-Jung Hung; Alex Tong-Long Lin (Urological Science, 2015)